Keratin containing implant material

Abstract

Methods for producing thin keratin films, sheets, and bulk materials, and products formed using these methods. One method includes providing hair, reducing the hair such that the disulfide linkages are broken and free cysteine thiol groups formed, separating out a more soluble keratin fraction in solution, forming a thin layer from the more soluble fraction, and air drying the keratin fraction in the presence of oxygen, thereby forming new disulfide bonds imparting strength to the resulting thin keratin film. One method includes reducing hair by heating the hair under nitrogen in an ammonium hydroxide and ammonium thioglycolate solution followed by centrifuging and collecting the supernatant containing the more soluble keratin fraction. The more soluble keratin in this method is precipitated using HCI, removed, and resuspended in ammonium hydroxide. The keratin solution thus formed is poured onto a flat surface and allowed to air dry into a thin keratin film. The film may be used as a wound dressing, a tissue-engineering scaffold, a diffusion membrane, a coating for implantable devices, and as a cell encapsulant. In another method, the keratin solution thus formed is concentrated, poured into a mold, and allowed to air dry into a three dimensional keratin product. The resulting bulk product can be used as a cross-linked implantable biomaterial for soft and hard tissue replacement. In another method, a keratin solution is emulsified and freeze dried, forming a porous, open cell keratin material.

What is claimed is:  
     
         1 . A tissue engineering scaffold comprising a keratin having added hydrophilic groups bound to said keratin, wherein said keratin is bound together with bonds consisting essentially of keratin-to-keratin disulfide bonds.  
     
     
         2 . The tissue engineering scaffold of  claim 1 , wherein said keratin is primarily beta keratin.  
     
     
         3 . The tissue engineering scaffold of  claim 2 , wherein said keratin is at least 80% beta keratin.  
     
     
         4 . The tissue engineering scaffold of  claim 1 , wherein said keratin is derived from hair.  
     
     
         5 . The tissue engineering scaffold of  claim 4 , wherein said hair is human hair  
     
     
         6 . The tissue engineering scaffold of  claim 1 , wherein said keratin contains sulfonic acid groups.  
     
     
         7 . The tissue engineering scaffold of  claim 6 , wherein said keratin contains cysteinethioglycollate disulfide residues.  
     
     
         8 . The tissue engineering scaffold of  claim 2 , wherein said keratin contains sulfonic acid groups.  
     
     
         9 . The tissue engineering scaffold of  claim 8 , wherein said keratin contains cysteinethioglycollate disulfide residues.  
     
     
         10 . A method of engineering tissue comprising the implantation of a tissue engineering scaffold comprising a keratin having added hydrophilic groups bound to said keratin, wherein said keratin is bound together with bonds consisting essentially of keratin-to-keratin disulfide bonds.  
     
     
         11 . The method of  claim 10 , wherein said keratin is primarily beta keratin.  
     
     
         12 . The method of  claim 11 , wherein said keratin is at least 80% beta keratin.  
     
     
         13 . The method of  claim 10 , wherein said keratin is derived from hair.  
     
     
         14 . The method of  claim 13 , wherein said hair is human hair.  
     
     
         15 . The method of  claim 10 , wherein said keratin contains sulfonic acid groups.  
     
     
         16 . The method of  claim 15 , wherein said keratin contains cysteine-thioglycollate disulfide residues.  
     
     
         17 . The method of  claim 11 , wherein said keratin contains sulfonic acid groups.  
     
     
         18 . The method of  claim 17 , wherein said keratin contains cysteine-thioglycollate disulfide residues.  
     
     
         19 . The method of  claim 1 , wherein said method if a method for engineering bone tissue.  
     
     
         20 . The method of  claim 1 , wherein said method if a method for engineering cartilage tissue.